Dustin Robinson joins Ryan Alford to discuss the growing body of scientific research surrounding psychedelic medicine and why mental health innovation may be entering a new era. As an attorney, investor, and advocate for responsible legal reform, Dustin explains how compounds once dismissed by society are now being studied for PTSD, depression, anxiety, and neurodegenerative diseases.
Ryan and Dustin explore FDA clinical trials, neuroplasticity, the importance of evidence-based medicine, and why responsible regulation is key to unlocking these therapies safely. They also discuss non-hallucinogenic psychedelics, Alzheimer’s research, virtual reality treatments, and how innovation could reshape the future of behavioral health.
Topics Covered
Psychedelic medicine research
PTSD and MDMA therapy
Depression and psilocybin
Neuroplasticity
Alzheimer’s and dementia
FDA clinical trials
Responsible legalization
Mental health innovation
Virtual reality therapeutics
Ryan Alford and Dustin Robinson on the future of behavioral health
Links
Dustin Robinson
Instagram: https://www.instagram.com/dustinr10/
ETHER Investments: https://etherinvestments.com
Ryan Alford
https://www.instagram.com/ryanalford/
https://vibesciencepodcast.com
